The discovery and characterization of the main causative agent of non-A, non-B hepatitis
(NANBH) represent a major success in the application of cloning techniques in the …

Lack of a small animal model of the human hepatitis C virus (HCV) has impeded
development of antiviral therapies against this epidemic infection. By transplanting normal …

Genotypes of hepatitis C virus (HCV) present within 104 samples from HCV-infected
individuals from Africa, the Middle East, the Indian subcontinent and South-East Asia were …

A method is described for identifying different genotypes of hepatitis C virus (HCV) by
restriction endonuclease cleavage of sequences amplified by PCR from the 5′ non-coding …

Hepatitis C Virus infection accounts for the majority of post-transfusion and sporadic
hepatitis. In Western Europe, anti-HCV is detected in 0.4–1.5% of healthy blood donors …

A large share of hepatitis C virus amino acid sequence variation is concentrated within two
hypervariable regions located at the N-terminus of the E2 envelope glycoprotein (HVR1 and …

The frequency and dynamics of infection with different genotypes of hepatitis C virus were
investigated in a cohort of hemophiliacs repeatedly exposed to non-virus-inactivated clotting …

Genotyping of hepatitis C virus (HCV) is important because of its clinical and
epidemiological implications. We report here the distribution of HCV genotypes in various …

Hepatitis C virus genotypes were determined for 358 viremic individuals in Montreal,
Canada, by restriction endonuclease analysis of PCR products and phylogenetic analysis of …

In this study we have determined the hepatitis C virus (HCV) serotype and genotype in a
cohort of 96 HCV-infected hemophiliacs and have examined the relationship between HCV …